EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

The CD4+ T cell repertoire specific for citrullinated peptides shows evidence of immune tolerance

Matthew K McElwee iD, Thamotharampillai Dileepan iD, Shawn A Mahmud iD, Marc K Jenkins iD

Journal of Experimental Medicine · 2023

DOI: 10.1084/jem.20230209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2023. Verfasst von Matthew K McElwee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunology, University of Minnesota Medical School , Minneapolis, MN, USA. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, CD4-Positive T-Lymphocytes, Immune Tolerance. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis occurs most often in people who express HLA-DR molecules containing a five aa “shared epitope” in the β chain. These MHCII molecules preferentially bind citrullinated peptides formed by posttranslational modification of arginine. Citrullinated peptide:HLA-DR complexes may act as arthritis-initiating neo-antigens for CD4+ T cells. Here, we used fluorophore-conjugated HLA-DR tetramers containing citrullinated peptides from human cartilage intermediate layer protein, fibrinogen, vimentin, or enolase 1 to track cognate CD4+ T cells. Immunization of HLA-DR transgenic mice with citrullinated peptides from vimentin or enolase 1 failed to cause any expansion of tetramer-binding cells, whereas immunization with citrullinated peptides from cartilage intermediate layer protein or fibrinogen elicited some expansion. The expanded tetramer-binding populations, however, had lower T helper 1 and higher regulatory T cell frequencies than populations elicited by viral peptides. These results indicate that HLA-DR–bound citrullinated peptides are not neo-antigens and induce varying degrees of immune tolerance that could pose a barrier to rheumatoid arthritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidCD4-Positive T-LymphocytesImmune ToleranceAnimalsHumansMiceFibrinogenHLA-DR AntigensMice, TransgenicPeptidesPeptides, CyclicPhosphopyruvate HydrataseVimentinCitrullination

Substanzen

FibrinogenHLA-DR AntigensPeptidesPeptides, CyclicPhosphopyruvate HydrataseVimentin

Autor:innen und Institutionen

  • Center for Immunology, University of Minnesota Medical School , Minneapolis, MN, USA.
  • Division of Rheumatic and Autoimmune Diseases, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Division of Pediatric Rheumatology, Allergy and Immunology, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN, USA.

ORCID-Profile: Matthew K McElwee, Thamotharampillai Dileepan, Shawn A Mahmud, Marc K Jenkins

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Rheumatology Research Foundation Scientist Development Award

Zitieren

APA

McElwee, M. K., Dileepan, T., Mahmud, S. A., & Jenkins, M. K. (2023). The CD4+ T cell repertoire specific for citrullinated peptides shows evidence of immune tolerance. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20230209

Vancouver

McElwee MK, Dileepan T, Mahmud SA, Jenkins MK. The CD4+ T cell repertoire specific for citrullinated peptides shows evidence of immune tolerance. Journal of Experimental Medicine. 2023. doi:10.1084/jem.20230209

BibTeX
@article{McElwee2023,
  author = {McElwee, Matthew K and Dileepan, Thamotharampillai and Mahmud, Shawn A and Jenkins, Marc K},
  title = {The CD4+ T cell repertoire specific for citrullinated peptides shows evidence of immune tolerance},
  journal = {Journal of Experimental Medicine},
  year = {2023},
  doi = {10.1084/jem.20230209}
}
Kostenlos starten →